ERC Consolidator Grant · 2019
Predicting Outcome of Rate or Rhythm Control in Patients with Atrial Fibrillation and Heart Failure
Heart failure (HF) and atrial fibrillation (AF) are common co-morbidities (AF-HF). AF-HF is prevalent in Europe with high rates of hospitalisation and death. AF-HF patients have two treatment options: rate control, where AF is not treated but drugs are used to slow the heart rate, or rhythm control, where AF is treated to restore sinus rhythm. Rate control is the first-line treatment, yet specific patient groups do much better under rhythm control. Identifying patients that will do best under rhythm control remains a significant clinical challenge. Potential responders to rhythm control can be identified by their disease history, however, this is often unknown, or their response to…
From the public funding record at EU CORDIS. Describes the funded project, not the reviews below.